Inogen Inc (INGN) Stock Price, Quote & News

Company Profile

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen...

Industry: Medical Devices

Sector: Healthcare

Phone: 805 562 0500

Website: www.provider.inogen.com

Address:

500 Cummings Center, Suite 2800, Beverly, United States

OfficialStocktwitsUser Mar. 10 at 9:04 PM

$INGN RSI: 59.61, MACD: 0.0767 Vol: 0.28, MA20: 6.05, MA50: 6.20 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Exo_blazzin Feb. 27 at 1:12 AM

$INGN so frustrating, it actually has a strong day, then just casually drops .50 cents after hours

0 · Reply

imraven Feb. 26 at 8:22 PM

$INGN Keep in mind, It is still undervalued than book price.

0 · Reply

ZacksResearch Feb. 25 at 6:42 PM

$INGN's Q4 surprise: Narrower loss, but shares slip! 🤔 💡 Adjusted loss per share of 15 cents beat estimates, yet revenue missed slightly & shares dropped nearly 5% in after-market trading. Strong international sales couldn't offset weaker U.S. performance. Complete risk/reward breakdown here 👉 https://www.zacks.com/stock/news/2875401/inogen-stock-dips-despite-q4-earnings-beat-revenues-up-yy?cid=sm-stocktwits-2-2875401-body-35194&ADID=SYND_STOCKTWITS_TWEET_2_2875401_BODY_35194

1 · Reply

johnfahmytut Feb. 25 at 6:07 PM

$INGN bests expectations and cashed up with 7M shares float. No debt.

0 · Reply

johnfahmytut Feb. 25 at 6:06 PM

$INGN $7 today

0 · Reply

ZacksResearch Feb. 25 at 5:42 PM

$INGN beats… but the stock slips ⚠️ Q4 delivered a narrower loss and a 2% revenue rise, yet shares dipped as U.S. sales and rentals weakened — even with international strength helping offset the pressure. Is this short-term noise or a deeper issue? Get the full breakdown 👉 https://www.zacks.com/stock/news/2875401/inogen-stock-dips-despite-q4-earnings-beat-revenues-up-yy?cid=sm-stocktwits-2-2875401-teaser-35191&ADID=SYND_STOCKTWITS_TWEET_2_2875401_TEASER_35191

0 · Reply

StockAuthority Feb. 25 at 4:03 PM

$INGN this will go higher as the Buy back gets moving. They also beat expectations last night so look for red to green and higher prices in coming days

0 · Reply

Crowbar20 Feb. 25 at 2:28 PM

$INGN $3’s incoming. Gonna get destroyed. Horrible ER. Market about to punish them.

1 · Reply

briefingcom Feb. 25 at 12:54 PM

$INGN: Inogen (-6.8%) has authorized a share repurchase program for up to $30 mln of its outstanding common stock

1 · Reply

Inogen Announces Participation in the KeyBanc Virtual Life Sciences & MedTech Investor Forum

Feb 24, 2026, 9:07 PM EST - 18 days ago

Inogen, Inc. (INGN) Q4 2025 Earnings Call Transcript

Feb 24, 2026, 4:05 PM EST - 18 days ago

Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook

Feb 24, 2026, 4:00 PM EST - 18 days ago

Inogen Announces $30 Million Share Repurchase Program

Jan 12, 2026, 8:30 AM EST - 2 months ago

Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025

Jan 7, 2026, 8:30 AM EST - 2 months ago

Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States

Nov 11, 2025, 3:01 PM EST - 4 months ago

Slow Progress At Inogen

Nov 5, 2025, 5:01 PM EST - 4 months ago

Inogen, Inc. (INGN) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 7:30 AM EST - 4 months ago

Inogen Announces Third Quarter 2025 Financial Results

Oct 15, 2025, 8:30 AM EDT - 5 months ago

Inogen to Report Third Quarter 2025 Financial Results on November 5, 2025

Sep 25, 2025, 4:05 PM EDT - 6 months ago

Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer

Aug 8, 2025, 6:18 PM EDT - 7 months ago

Inogen, Inc. (INGN) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 7 months ago

Inogen Announces Second Quarter 2025 Financial Results

Jul 17, 2025, 8:30 AM EDT - 8 months ago

Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025

Jun 23, 2025, 8:30 AM EDT - 9 months ago

Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy

May 22, 2025, 1:38 PM EDT - 10 months ago

Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough

May 7, 2025, 8:16 PM EDT - 11 months ago

Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 11 months ago

Inogen Announces First Quarter 2025 Financial Results

Mar 20, 2025, 8:30 AM EDT - 1 year ago

Inogen To Present at 24th Annual Needham Virtual Healthcare Conference

Mar 1, 2025, 8:56 AM EST - 1 year ago

A Volatile Share Price Masks Some Of The Progress At Inogen

Feb 26, 2025, 4:21 PM EST - 1 year ago

What's Going On With MedTech Focused Inogen Stock On Wednesday?

Feb 25, 2025, 8:03 PM EST - 1 year ago

Inogen, Inc. (INGN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 4:05 PM EST - 1 year ago

Inogen Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 3, 2025, 4:00 PM EST - 1 year ago

Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

Jan 26, 2025, 10:17 PM EST - 1 year ago

Arab Health 2025｜Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health

Jan 26, 2025, 12:00 PM EST - 1 year ago

Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell

Jan 13, 2025, 4:00 PM EST - 1 year ago

Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

Dec 30, 2024, 8:30 AM EST - 1 year ago

Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device

Nov 9, 2024, 9:55 PM EST - 1 year ago

Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 1 year ago

Inogen Announces Third Quarter 2024 Financial Results

Nov 4, 2024, 8:30 AM EST - 1 year ago

Inogen to Present at Upcoming Investor Conferences

Oct 17, 2024, 8:30 AM EDT - 1 year ago

Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024

Oct 8, 2024, 8:30 AM EDT - 1 year ago

Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC

Sep 5, 2024, 8:30 AM EDT - 1 year ago

Inogen Appoints Eric Pauls as Vice President of Sales, North America

Aug 6, 2024, 9:11 PM EDT - 1 year ago

Inogen, Inc. (INGN) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces Second Quarter 2024 Financial Results

Jul 16, 2024, 8:30 AM EDT - 1 year ago

Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024

Jul 3, 2024, 4:10 PM EDT - 1 year ago

Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development

Jun 3, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio

May 7, 2024, 10:30 PM EDT - 2 years ago

Inogen, Inc. (INGN) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 2 years ago

Inogen Announces First Quarter 2024 Financial Results

Apr 10, 2024, 8:30 AM EDT - 2 years ago

Inogen to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 25, 2024, 8:30 AM EDT - 2 years ago

Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference

Mar 7, 2024, 4:00 PM EST - 2 years ago

Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Feb 27, 2024, 7:09 PM EST - 2 years ago

Inogen, Inc. (INGN) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 2 years ago

Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results

Jan 30, 2024, 4:00 PM EST - 2 years ago

Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Jan 24, 2024, 4:00 PM EST - 2 years ago

Inogen Names Michael Bourque as New Chief Financial Officer

Jan 1, 2024, 8:47 AM EST - 2 years ago

Inogen: Time To Be Greedy When Others Are Fearful

Nov 9, 2023, 2:30 PM EST - 2 years ago

Inogen to Present at Upcoming Investor Conferences in November 2023

OfficialStocktwitsUser Mar. 10 at 9:04 PM

0 · Reply

Exo_blazzin Feb. 27 at 1:12 AM

$INGN so frustrating, it actually has a strong day, then just casually drops .50 cents after hours

0 · Reply

imraven Feb. 26 at 8:22 PM

$INGN Keep in mind, It is still undervalued than book price.

0 · Reply

ZacksResearch Feb. 25 at 6:42 PM

1 · Reply

johnfahmytut Feb. 25 at 6:07 PM

$INGN bests expectations and cashed up with 7M shares float. No debt.

0 · Reply

johnfahmytut Feb. 25 at 6:06 PM

$INGN $7 today

0 · Reply

ZacksResearch Feb. 25 at 5:42 PM

0 · Reply

StockAuthority Feb. 25 at 4:03 PM

$INGN this will go higher as the Buy back gets moving. They also beat expectations last night so look for red to green and higher prices in coming days

0 · Reply

Crowbar20 Feb. 25 at 2:28 PM

$INGN $3’s incoming. Gonna get destroyed. Horrible ER. Market about to punish them.

1 · Reply

briefingcom Feb. 25 at 12:54 PM

$INGN: Inogen (-6.8%) has authorized a share repurchase program for up to $30 mln of its outstanding common stock

1 · Reply

Fringe Feb. 25 at 11:34 AM

$INGN does $5 hold? Buyback mentioned to hide the bad ER. They used to help but not anymore. Lets see how low the market takes this today.

0 · Reply

StockAuthority Feb. 25 at 4:53 AM

$INGN good DD. Let the share buyback support us now, 7.2 book value

1 · Reply

imraven Feb. 25 at 1:40 AM

$INGN Summary 1. Book value per share 7.2. This is the one of the reason for share buy back. 2. Debt free 3. 20.4 Million shares out of 27 Million shares are held by institution. 4. Insider has been buying shares in last 12 months. No Insider sell in last 12 months. Negative EPS is the only concern. Main focus from management to make company profitable. I will add more tomorrow morning if it dips further.

0 · Reply

StockAuthority Feb. 25 at 12:07 AM

$INGN 6s tomorrow, 👍

0 · Reply

SwallowTheLeader Feb. 24 at 11:42 PM

$INGN pump and dump

0 · Reply

Investor7952 Feb. 24 at 11:34 PM

$INGN If earnings andvthingscarecdo good why is it down 8% ? Come on wake up. You follow these clowns that tell you to buy and they constant lead you to the wood shed. Like Professor D man every day dirceeek pumping OCG from $1.91 yelling 1000 % gainer! Then at $1.65 $1000 % gainer the China mafia is coming to buy it! Then and $1.05 going up 1000% tomorrow guaranteed! Now at .63 cents that moron never came out to apologize for leading the sheep to the slaughter house! He’s an ass

0 · Reply

StockAuthority Feb. 24 at 11:02 PM

$INGN share buyback and they beat expectations, this will open higher and go higher over coming days as company buys back shares

1 · Reply

AngryRed316 Feb. 24 at 10:33 PM

$INGN Benzinga dropped the ball here. How it’s legal for them to post fake news then retract it manipulating the price is beyond me. L for me here

1 · Reply

Warrent_jr Feb. 24 at 10:12 PM

$INGN $3

0 · Reply

imraven Feb. 24 at 9:47 PM

$INGN looks good to me

0 · Reply

BuyRightAndWaitForProfit Feb. 24 at 9:39 PM

$INGN 🙏🚀

0 · Reply

StockAuthority Feb. 24 at 9:38 PM

$INGN this is HUGE $INGN Announced $30M repurchase program Sees Q1 sales $366M-$373M vs $90M estimate $XWEL $EDSA $TLIH

4 · Reply

Market Cap	165.03M
Revenue (ttm)	348.67M
Net Income (ttm)	-22.75M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-6.52%
Debt to Equity Ratio	0.00

Volume	179,500
Avg Vol	287,628
Day's Range	N/A - N/A
Shares Out	27.23M
Stochastic %K	8%
Beta	1.77
Analysts	Sell
Price Target	$13.00